(San Francisco, CA) The California Institute for Regenerative Medicine (CIRM) awarded $60 million to researchers hoping to accelerate the development of a treatment for type I diabetes.
Stem Cell Agency Invests $16 million To Fight Diabetes (Imperial Valley News)
ViaCyte is developing diabetes bioproducts